TVTX CIK: 1438533

Travere Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
128
FY22:
105
FY23:
134
FY24:
225
FY25:
480
(positive)
Change from FY21 to FY25
millions USD
FY21:
−199
FY22:
−320
FY23:
−388
FY24:
−324
FY25:
−62.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−184
FY22:
−292
FY23:
–
FY24:
–
FY25:
22.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−217
FY22:
−331
FY23:
−376
FY24:
−321
FY25:
−49.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−180
FY22:
−278
FY23:
−111
FY24:
−322
FY25:
−25.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data